Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Glaukos
GKOS
$10.7B
| $13.1M | 0.01% |
240,869
+21,591
| +10% | +$1.31M |
|
|
UFS
1502
DELISTED
DOMTAR CORPORATION (New)
UFS
| $13.1M | 0.01% |
342,026
-40,146
| -11% | -$1.49M |
|
|
RAD
1503
DELISTED
Rite Aid Corporation
RAD
| $13.1M | 0.01% |
844,286
+94,287
| +13% | +$923K |
|
|
KEM
1504
DELISTED
KEMET Corporation
KEM
| $13.1M | 0.01% |
482,683
+23,158
| +5% | +$562K |
|
1505
Insmed
INSM
$29B
| $13.1M | 0.01% |
546,594
+11,348
| +2% | +$231K |
|
|
MNTA
1506
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $13M | 0.01% |
660,010
+69,800
| +12% | +$1.12M |
|
1507
Medifast
MED
$130M
| $13M | 0.01% |
118,467
+327
| +0.3% | +$31.6K |
|
1508
Herc Holdings
HRI
$5.72B
| $13M | 0.01% |
265,064
+6,992
| +3% | +$326K |
|
1509
Oxford Industries
OXM
$542M
| $12.9M | 0.01% |
171,432
+6,493
| +4% | +$469K |
|
|
TGI
1510
DELISTED
Triumph Group
TGI
| $12.9M | 0.01% |
511,442
-71,242
| -12% | -$1.77M |
|
|
PRFT
1511
DELISTED
Perficient Inc
PRFT
| $12.9M | 0.01% |
279,946
-3,254
| -1% | -$133K |
|
1512
Kinsale Capital Group
KNSL
$8.53B
| $12.9M | 0.01% |
126,613
+2,872
| +2% | +$286K |
|
1513
Community Health Systems
CYH
$400M
| $12.9M | 0.01% |
4,436,713
-156,830
| -3% | -$543K |
|
1514
Trinity Industries
TRN
$2.29B
| $12.8M | 0.01% |
579,479
+548
| +0.1% | +$11.2K |
|
|
GMS
1515
DELISTED
GMS Inc
GMS
| $12.8M | 0.01% |
473,845
+21,236
| +5% | +$623K |
|
|
NTUS
1516
DELISTED
Natus Medical Inc
NTUS
| $12.8M | 0.01% |
388,570
+35,434
| +10% | +$1.14M |
|
1517
Tennant Co
TNC
$1.13B
| $12.8M | 0.01% |
163,837
-3,295
| -2% | -$245K |
|
1518
Ironwood Pharmaceuticals
IRWD
$711M
| $12.8M | 0.01% |
958,154
+22,384
| +2% | +$247K |
|
|
HEES
1519
DELISTED
H&E Equipment Services
HEES
| $12.7M | 0.01% |
381,162
-10,528
| -3% | -$341K |
|
1520
Canadian National Railway
CNI
$76.4B
| $12.7M | 0.01% |
140,594
+106,024
| +307% | +$9.53M |
|
1521
Astec Industries
ASTE
$989M
| $12.7M | 0.01% |
302,185
+1,728
| +0.6% | +$62.7K |
|
1522
Oceaneering
OII
$5.05B
| $12.7M | 0.01% |
850,446
+29,402
| +4% | +$409K |
|
1523
Casella Waste Systems
CWST
$5.89B
| $12.7M | 0.01% |
275,460
+8,811
| +3% | +$389K |
|
|
ARCH
1524
DELISTED
Arch Resources, Inc.
ARCH
| $12.7M | 0.01% |
176,531
+7,664
| +5% | +$587K |
|
1525
Andersons Inc
ANDE
$2.18B
| $12.7M | 0.01% |
500,529
+22,442
| +5% | +$490K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.